Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Transition to KPL-387 Monotherapy Dosing & Administration Study

ClinicalTrials.gov ID: NCT07288216

Public ClinicalTrials.gov record NCT07288216. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Posology Study With Long-Term Extension in Participants With Well-Controlled Recurrent Pericarditis to Evaluate the Efficacy and Safety of Transition Regimens to KPL-387 Monotherapy From Standard Therapies

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to characterize the efficacy and safety of dosing regimens used to transition from prior pericarditis therapies to KPL-387 monotherapy in participants with well-controlled recurrent pericarditis on standard therapies.

Study identification

NCT ID
NCT07288216
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Enrollment
120 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 25, 2026 (Actual)
Primary completion
Dec 31, 2027 (Estimated)
Completion
Dec 31, 2029 (Estimated)
Last update posted
Oct 20, 2026

2026 – 2029

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Investigational Site 031 Phoenix Arizona 85054 Recruiting
Investigational Site 045 La Jolla California 92037 Recruiting
Investigational Site 014 Los Angeles California 90048 Recruiting
Investigational Site 002 Santa Monica California 90404 Recruiting
Investigational Site 046 Washington D.C. District of Columbia 20010 Recruiting
Investigational Site 039 Jacksonville Florida 32224 Recruiting
Investigational Site 013 Chicago Illinois 60611 Recruiting
Investigational Site 025 Baltimore Maryland 21287 Recruiting
Investigational Site 043 Boston Massachusetts 02199 Recruiting
Investigational Site 028 Rochester Minnesota 55905 Recruiting
Investigational Site 042 St Louis Missouri 63130 Recruiting
Investigational Site 011 New York New York 10016 Recruiting
Investigational Site 003 New York New York 10032 Recruiting
Investigational Site 009 Cincinnati Ohio 45219 Recruiting
Investigational Site 040 Cleveland Ohio 44195 Recruiting
Investigational Site 005 Austin Texas 78705 Recruiting
Investigational Site 047 Dallas Texas 75235 Recruiting
Investigational Site 006 Houston Texas 77030 Recruiting
Investigational Site 004 Charlottesville Virginia 22903 Recruiting
Investigational Site 001 Norfolk Virginia 23507 Recruiting
Investigational Site 008 Richmond Virginia 23284 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07288216, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 20, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07288216 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →